• Most Popular
  • Most Shared

Bayer gets Japan approval for kidney cancer drug

TOKYO
Mon Jan 28, 2008 7:00am EST
A laboratory researcher in a file photo. German drug maker Bayer AG said on Monday that its drug Nexavar had been approved in Japan for the treatment of kidney cancer. REUTERS/Sebastian Derungs

TOKYO (Reuters) - German drug maker Bayer AG said on Monday that its drug Nexavar had been approved in Japan for the treatment of kidney cancer.

Health

Last week, Japanese health authorities granted priority review status for Nexavar to treat liver cancer.

(Reporting by Edwina Gibbs)
Health


More from Reuters

An image of U.S. President Barack Obama is seen in an exhibition at the Nobel Peace Centre in Oslo December 9, 2009. Two leading international human rights groups gave Obama mixed reviews on his human rights record on Wednesday, a day before he is slated to accept the 2009 Nobel Peace Prize in Oslo. Human Rights Watch and Amnesty International urged Obama to use his acceptance speech on Thursday to renew U.S. leadership on human rights after its position was undermined by abuses committed during the Bush administration's war on terrorism. REUTERS/Chris Helgren

Copenhagen: What of Obama?

President Barack Obama’s decision to attend the climate talks in Copenhagen is said to show the White House is serious about pursuing a deal to curb global warming. What should Obama commit to on climate change? Share your views.  Full Article | Related Story 

    Climate Conference
    Tom Metzold, Vice President of Eaton Vance Management and Senior Portfolio Manager at Eaton Vance, speaks at the Reuters Global Media Summit in New York, December 9, 2009. REUTERS/Brendan McDermid

    "Everything's not hunky-dory"

    Did the worst downturn in 70 years leave a permanent scar? Top money managers like Tom Metzold examine how a "new normal" will shape things to come.  Full Article 

    Investment Outlook Summit
    A crown in a file photo. REUTERS/File
    Special Report:

    No longer king of the hill

    When times were good, hedge fund managers could do what they wanted and people still lined up for a piece of the action. What will the post-crash, post-Madoff, post-Galleon hedge fund universe look like?  Full Article 

    Hedge Funds